... adult employed audience who work in companies with 50+ employees—span a wide range of industries from IT and business services, to healthcare and pharma, to banking and finance, and construction and manufacturing and a wide range of titles and levels within their organisations.
... adult employed audience who work in companies with 50+ employees—span a wide range of industries from IT and business services, to healthcare and pharma, to banking and finance, and construction and manufacturing and a wide range of titles and levels within their organisations.
... adult employed audience who work in companies with 50+ employees—span a wide range of industries from IT and business services, to healthcare and pharma, to banking and finance, and construction and manufacturing and a wide range of titles and levels within their organizations.
It is sad to watch politicians indulge in power games while the majority struggle for just survival ... From auto to pharma to home appliances to oil and gas to engineering to fertiliser to cement to other construction allied industries to textiles, there is news of complete and partial closures almost every other day ... .
“If LTCG can be put to 0, that would be a good decision for long-term investors ... In an interview with ETMarkets, Gangil said ... , Rallis ... Yes, I think so and some sectors like pharma, financials, and construction will join them ... It should be infra, Pharma, and healthcare, govt should also clear its stand about crypto and supporting EVs ... 1 ... ... (Disclaimer ... .
Mumbai (Maharashtra), January 1 (ANI) ...Online trading platforms with easy registration and accessibility have spiked the number of investors in the domestic markets ... There is another looming threat of inflation to the markets ... "We are bullish on financials, capital goods, construction defence, and auto. Defensives would be FMCG and pharma ... (ANI) ....
By Bunty ThoidingjamMumbai (Maharashtra), December 31 (ANI) ... The Reserve Bank of India is also slowly hiking key policy rates to rein in inflation in the country ... Capital goods and cement have the potential to outperform." ... "We are bullish on financials, capital goods, construction defence, and auto. Defensives would be FMCG and pharma ... (ANI) ....
Sharekhan by BNP Paribas. has buy call on PI Industries. with a target price of Rs 4200. The current market price of PI Industries Ltd. is Rs 3542.05 ... Financials ... Investment Rationale potential acquisition inthe pharma space would improve long-term earnings growth outlook and makes us constructive on thestock ... Promoter/FII Holdings ... .
SAN ANTONIO, Dec ...Discover more by visiting the multi-media landing page ... Contact us ... P ... E ... The company provides innovative products and environmental solutions that contribute to its customers' competitiveness in multiple industries such as Construction, Paper & Board, Polymers, Food, Pharma, Personal & HomeCare, Agriculture, Water and Energy.
(MENAFN - KNNIndia) India-Russia deepen trade ties across ICT, Pharma & construction sectors New Delhi, Dec 19 (KNN) Sanction-hit Russia is making major efforts to boost its business ... .
Exports to the region from companies supported by Enterprise Ireland reached a record high of €1.24bn in 2021, up 31pc on 2020.As many as 560 Irish companies that Enterprise Ireland support are exporting to the Nordic region.These represent innovators not only from agribusiness, ...
Reliance LifeScience, a subsidiary of Reliance Industries Ltd, has begun the construction work of setting up a unit to manufacture pharma products at a cost of Rs 4,200 crore. MIDC has allotted 160 acres to the company to set up the manufacturing plant and the company has already started construction activities at the site.
The pharma firm had denied constructively dismissing the complainant ... investigators of subjecting him to “blackmail” and “the most humiliating experience of my life” during a data audit has lost his claim for constructive dismissal.
“We expect Cement, Construction & Infra, and SpecialityChemicals to hog the limelight. However, IT and Pharma can prove to be more resilient and can be considered as Contra exposure in the portfolio,” says Kedar Kadam, Director – Listed Investments, Waterfield Advisors.